[Skip to Content]
[Skip to Content Landing]

August 2017 - January 1908

Decade

Year

Issue

December 9, 2002, Vol 162, No. 22, Pages 2517-2647

Reviewers for 2002

Reviewers Who Completed a Review During 2002

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2643-2647. doi:10.1001/archinte.162.22.2643
Editorial

The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism

Abstract Full Text
Arch Intern Med. 2002;162(22):2521-2523. doi:10.1001/archinte.162.22.2521

Pain ManagementA Call for Papers

Abstract Full Text
Arch Intern Med. 2002;162(22):2524. doi:10.1001/archinte.162.22.2524
Original Investigation

Thrombolysis vs Heparin in the Treatment of Pulmonary EmbolismA Clinical Outcome–Based Meta-analysis

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2537-2541. doi:10.1001/archinte.162.22.2537

Treatment for Hepatitis C Virus in Human Immunodeficiency Virus–Infected PatientsClinical Benefits and Cost-effectiveness

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2545-2556. doi:10.1001/archinte.162.22.2545

Body Mass Index and the Risk of Stroke in Men

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2557-2562. doi:10.1001/archinte.162.22.2557

Risk Factors for Coronary Heart Disease in African AmericansThe Atherosclerosis Risk in Communities Study, 1987-1997

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2565-2571. doi:10.1001/archinte.162.22.2565

Weight Change, Weight Fluctuation, and Mortality

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2575-2580. doi:10.1001/archinte.162.22.2575

Effect of Medicare Coverage on Use of Invasive Colorectal Cancer Screening Tests

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2581-2586. doi:10.1001/archinte.162.22.2581

Plasma Measurement of D-Dimer Levels for the Early Diagnosis of Ischemic Stroke Subtypes

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2589-2593. doi:10.1001/archinte.162.22.2589

Diabetes, Plasma Insulin, and Cardiovascular DiseaseSubgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT)

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2597-2604. doi:10.1001/archinte.162.22.2597

Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2605-2609. doi:10.1001/archinte.162.22.2605

Depressive Symptoms, Unemployment, and Loss of IncomeThe CARDIA Study

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2614-2620. doi:10.1001/archinte.162.22.2614

Incidence of Adipose Tissue Alterations in First-Line Antiretroviral TherapyThe LipoICoNa Study

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2621-2628. doi:10.1001/archinte.162.22.2621
Review Article

Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseA Systematic Review

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2527-2536. doi:10.1001/archinte.162.22.2527
In This Issue of Archives of Internal Medicine

In This Issue of Archives of Internal Medicine

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):2517. doi:10.1001/archinte.162.22.2517
Editor's Correspondence

Medication Assistance Programs: Eligibility and Enrollment

Abstract Full Text
Arch Intern Med. 2002;162(22):2629. doi:

Medication Assistance Programs: Eligibility and Enrollment—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2629. doi:

Combined Vitamin E and Vitamin C Supplement Use and Risk of Cardiovascular Disease Mortality

Abstract Full Text
Arch Intern Med. 2002;162(22):2630. doi:

Combined Vitamin E and Vitamin C Supplement Use and Risk of Cardiovascular Disease Mortality—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2630. doi:

Reflections on Malpractice

Abstract Full Text
Arch Intern Med. 2002;162(22):2630. doi:

"Defensive Medicine" and Malpractice Suits

Abstract Full Text
Arch Intern Med. 2002;162(22):2631. doi:

Practicing Patient-Centered Medicine Each Day Won't Keep the Lawyers Away

Abstract Full Text
Arch Intern Med. 2002;162(22):2631. doi:

Ten Points for a National Health Plan

Abstract Full Text
Arch Intern Med. 2002;162(22):2631. doi:

Ten Points for a National Health Plan—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2632. doi:

Nicotine Lozenge Trial: A "Real-World" Perspective

Abstract Full Text
Arch Intern Med. 2002;162(22):2632. doi:

Nicotine Lozenge Trial: A "Real-World" Perspective—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2633. doi:

The Impact of Hospitalists on Congestive Heart Failure

Abstract Full Text
Arch Intern Med. 2002;162(22):2633. doi:

The Impact of Hospitalists on Congestive Heart Failure—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2634. doi:

Periodontitis in Estrogen-Deficient Women

Abstract Full Text
Arch Intern Med. 2002;162(22):2634. doi:

Periodontitis in Estrogen-Deficient Women—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2635. doi:

Intraventricular Block and Atrioventricular Conduction

Abstract Full Text
Arch Intern Med. 2002;162(22):2635. doi:

Using Trade Names: Sometimes It Helps

Abstract Full Text
Arch Intern Med. 2002;162(22):2636. doi:

Trade Name, INNs, and Medication Errors

Abstract Full Text
Arch Intern Med. 2002;162(22):2636. doi:

Trade Name, INNs, and Medication Errors—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2636. doi:

Lack of Cardioprotective Effect of Naproxen

Abstract Full Text
Arch Intern Med. 2002;162(22):2637. doi:

Aspirin Use May Change Cost-effectiveness of COX-2 Inhibitors

Abstract Full Text
Arch Intern Med. 2002;162(22):2637. doi:

Aspirin Use May Change Cost-effectiveness of COX-2 Inhibitors—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2638. doi:

Cyclooxygenase-2 Inhibitors and Myocardial Infarction

Abstract Full Text
Arch Intern Med. 2002;162(22):2639. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain

Abstract Full Text
Arch Intern Med. 2002;162(22):2639. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2640. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2641. doi:

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Abstract Full Text
Arch Intern Med. 2002;162(22):2642. doi:
CME Announcement

CME Hiatus: July Through December 2002

Abstract Full Text
free access
Arch Intern Med. 2002;162(22):e2536. doi:10.1001/archinte.163.9.1075
×